The U.K. National Institute for Health and Care Excellence has recommended that physicians in the U.K. use the least ...

Medtronic plc expects its Hugo robotic-assisted surgery system to be a key growth driver, especially when it receives U.S.

Cardiac hypertrophy is a main contributor to heart failure, where therapeutic options are limited. Increasing evidence exists ...

The U.S. FDA has cleared Artrya Ltd.’s 510(k) for its Salix coronary plaque (SCP) module that is a bolt-on module to the ...

Deficiencies in interferon-stimulated gene 15 (ISG15), a protein that normally regulates the immune response, causes mild but ...

Shattuck Labs Inc. has reported that its IND from the U.S. FDA for SL-325 for the treatment of inflammatory bowel disease is ...

An investigation of the epidemiology and clinical characteristics of neuropathic pain in the UK Biobank has led to the ...

Aclarion Inc.'s Nociscan, an AI-augmented platform that leverages MR spectroscopy to noninvasively identify the discs causing low-back pain, enables precise targeting of surgical intervention, ...

Multiple datasets are due to roll out soon in the Prader-Willi syndrome (PWS) space, where contenders are trying varied mechanisms of action to tackle the rare genetic disorder characterized by ...

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by the formation of an invasive and proliferative ...

The U.S. FDA approved 17 drugs in July, down from 23 in June, bringing the year-to-date total to 125. Through July, 2025 remains the third-highest count in BioWorld’s records, trailing 135 approvals ...

Signos Inc. landed U.S. FDA clearance for its over-the-counter glucose monitoring system, which combines Dexcom Inc.'s ...